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dorsolateral Prefrontal Cortex Activity Predicts
esponsiveness to Cognitive–Behavioral Therapy
n Schizophrenia
eena Kumari, Emmanuelle R. Peters, Dominic Fannon, Elena Antonova, Preethi Premkumar,
nantha P. Anilkumar, Steven C.R. Williams, and Elizabeth Kuipers
ackground: Given the variable response to cognitive–behavioral therapy (CBT)when added to antipsychoticmedication in psychosis and the
vidence for a role of pretherapy level of frontal lobe–based cognitive function in responsiveness to CBT in other disorders, this study examined
hether pretherapy brain activity associatedwithworkingmemory neural network predicts clinical responsiveness to CBT in schizophrenia.
ethods: Fifty-two outpatients stable onmedication with at least one distressing symptom of schizophrenia andwilling to receive CBT in
ddition to their usual treatment and20healthyparticipantsunderwent functionalmagnetic resonance imagingduringaparametricn-back
ask. Subsequently, 26 patients received CBT for psychosis (CBTtreatment-as-usual [TAU], 19 completers) for 6–8 months, and 26
ontinued with TAU alone (17 completers). Symptoms in both patient groups were assessed (blindly) at entry and follow-up.
esults: The CBTTAU and TAU-alone groups did not differ clinically or in performance at baseline. The CBTTAU group showed
ignificant improvement in relation to the TAU-alone group, which showed no change, at follow-up. Stronger dorsolateral prefrontal cortex
DLPFC) activity (within the normal range) and DLPFC–cerebellum connectivity during the highest memory load condition (2-back 
-back) were associated with post-CBT clinical improvement.
onclusions: DLPFC activity and its connectivity with the cerebellum predict responsiveness to CBT for psychosis in schizophrenia. These
ffects may be mediated by PFC–cerebellum contributions to executive processing.eyWords: CBT, cerebellum, connectivity, DLPFC, fMRI, psychosis,
chizophrenia
number of randomized controlled trials (RCTs) have
demonstrated that persistent positive symptoms, particu-
larly delusions, and secondary disturbances such as de-
ression, are improved by cognitive–behavioral therapy for
sychosis (CBT-P) in patients with schizophrenia (1–3). These
ffects, however, are seen with modest effect sizes and present,
o a noticeable degree, in only about 50% of such patients. Given
he variable response to CBT-P, it is important to elucidate the
redictors of CBT efficacy for psychosis.
Cognitive functions may play a role in CBT responsiveness
cross most disorders but perhaps more so in disorders, such as
chizophrenia, which are characterized by cognitive impairment
4). Although skilled therapy adaptations attempt to compensate
or such impairment, it may still hinder effectiveness of CBT,
erhaps by impeding patients’ ability to remember information
iscussed in sessions; to acquire new, more flexible thinking
tyles or coping strategies; or to generalize specific issues
iscussed in therapy to other situations in life. For example, in
epression better executive functioning and problem-solving
bility predict a more favorable clinical outcome following CBT,
ut not following treatment with antidepressant or placebo or
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vice Foundation Trust, London, United Kingdom.
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oi:10.1016/j.biopsych.2009.04.036waiting for CBT (5,6). Intact executive functioning also predicts a
favorable response to CBT for generalized anxiety disorder (7).
Similarly, initial cognitive flexibility predicted a better outcome in
an RCT of CBT-P (8). In a recent study (9), neurocognitive
deficits predicted poorer function overall in older psychotic
patients but did not moderate CBT effects. The therapy in this
study, however, was targeted specifically at social functioning
rather than at distress and symptom reduction. In general, clinical
responsiveness to CBT across disorders may relate to executive
processes (5–8) modulated by the frontal lobes, especially the
dorsolateral prefrontal cortex (DLPFC) (10–12).
This study tested the hypothesis, for the first time to our
knowledge, that pretherapy DLPFC activity, elicited with a
parametric n-back working memory (WM) task (13,14) and
detected with functional magnetic resonance imaging (fMRI),
would predict clinical responsiveness to CBT-P in schizophrenia.
Given known associations between impaired cognition and
disrupted DLPFC connectivity in schizophrenia (15), we also
examined DLPFC connectivity with other brain regions as a
predictor of responsiveness to CBT-P.
Methods andMaterials
Participants and Design
This investigation involved three groups. Group 1 consisted
of 26 outpatients with schizophrenia (16) who received CBT-P
for 6–8 months in addition to their treatment-as-usual (TAU;
CBTTAU), Group 2 of 26 outpatients with schizophrenia who
received TAU during the course of this investigation (TAU
alone), and Group 3 of 20 healthy participants (HC) who did not
have a clinical diagnosis (17).
All participants were right-handed and had no history of
neurological conditions or head injury. All patients 1) had been
on stable doses of antipsychotics for 2 years and on their
present antipsychotic for 3 months, 2) received a rating of 60
on the Positive and Negative Symptoms scale (PANSS) (18) and
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V. Kumari et al. BIOL PSYCHIATRY 2009;66:594–602 595eported at least one positive “distressing” symptom, and 3)
ished/agreed to receive 6–8 months of CBT-P in addition to
heir usual drug treatment. Patients for both (CBTTAU,
AU-alone) groups 1) were from the same geographic area, 2)
ad been identified by their psychiatrists as suitable for
BT-P, and 3) wished to receive CBT in addition to their usual
reatment. Those accepted for CBT-P by the Psychological
nterventions Clinic for Outpatients with Psychosis (PICuP),
outh London and Maudsley (SLAM) National Health Service
NHS) Foundation Trust went into the CBTTAU group;
thers, matched to those in the CBTTAU group as much as
ossible, went into the TAU-alone group. With the resources
vailable to the SLAM NHS Foundation Trust, only approxi-
ately 10% of eligible patients are offered CBT-P. The final
BTTAU group had 19 patients (consent withdrawal, n  4;
edication noncompliance before follow-up, n  1; nonus-
ble data, n  2), and the TAU-alone group had 17 patients
consent withdrawal, n  5; acutely unwell/admitted to a
ecure hospital before follow-up, n  2; nonusable data, n  2).
able 1 presents participants’ characteristics. All participants pro-
able 1. Demographics, Task Performance, and Clinical Characteristics of P
Healthy Partic
(n 20; 14
emographics Mean (SD
ge (Years) 33.20 (1
ducation (Years) 15.55 (2
redicted IQa 115.05 (7
erformance Mean (SE
ccuracy (%; Chance Performance 25%)
0-back 89.13 (2
1-back 76.29 (4
2-back 58.54 (5
eaction Time (msec)
0-back 136.78 (1
1-back 209.01 (3
2-back 296.79 (4
Patie
CBTTAU Group
Mean (SD)
linical Variables Baseline Follow-up
C
M
ge at Illness Onset (Years) 24.26 (7.91)
uration of Illness (Years) 10.74 (8.06)
Positive Symptoms 17.89 (4.86) ’14.79 (4.39)
Negative Symptoms 16.89 (3.52) 15.21 (4.04)
General Psychopathology 32.95 (5.27) ’28.05 (7.48)
Total Symptoms 67.74 (10.87) ’58.05 (14.93)
ntipsychotic medication 17 patients on atypical
and 2 on both
atypical and typical
antipsychotics.
As baseline
ntipsychotic Dose in
Chlorpromazine
Equivalents (mg)
544.00 (426.46) As baseline
Duration of illness  current age minus age of illness onset; aNationa
missing IQ data in one healthy participant) and IQ in healthy participants sig
o healthy participants even when controlling for age; ’Lower symptom s
Symptom reduction (p .05) in the CBTTAU, relative to the TAU-alone,CBT, cognitive-behavioral therapy; TAU, treatment-as-usual.vided written informed consent after the study procedures had been
explained to them.
All participants underwent fMRI during the n-back task and
clinical assessment at entry. The CBTTAU group then received
6–8 months of CBT-P following a published manual (19) in a
specialist clinical service (PICuP, SLAM NHS Foundation Trust).
Therapy sessions were conducted weekly or fortnightly, as
preferred by the patient, for up to 1 hour. Patients received an
average of 16 sessions. All CBT interventions were formulation-
driven and focused on the therapy goals of the patient. The
therapists were supervised by one of two investigators (E.K. or
E.R.P.). TAU-alone patients were followed up over the same
period as CBTTAU patients. Symptoms were rated in all
patients, using the PANSS (18), at entry and then 6–8 months later
by an experienced and independent psychiatrist (DF) who was
blind to whether patients received CBT.
fMRI Paradigm and Procedure
The task (14), modified from Callicott et al. (20), involved
monitoring locations of dots (presentation time: 450 msec;
pants
s
Patients
CBTTAU Group
(n 19, 14 men)
TAU-Alone Group
(n 17, 15 men)
Mean (SD) Mean (SD)
35.20 (7.79) 40.24 (10.34)
13.79 (3.34) 13.35 (1.54)
110.44 (9.75) 106.17 (8.63)
Mean (SEM) Mean (SEM)
86.18 (2.95) 88.08 (2.68)
65.56 (4.34) 75.97 (4.99)
45.18 (5.43) 44.52 (5.88)
209.07 (22.02) 207.56 (25.97)
222.52 (30.11) 274.58 (42.51)
562.23 (94.70) 426.08 (58.77)
nly
TAU-alone Group
Mean (SD)
e (Baseline
Follow-up) Baseline Follow-up
Change (Baseline
Minus Follow-up)
24.82 (8.43)
15.41 (12.21)
1 (3.88) 18.53 (3.10) 18.23 (3.67) 0.29 (4.13)
8 (3.90) 18.82 (3.94) 20.06 (4.53) 1.24 (4.38)
9 (7.06) 34.82 (4.72) 34.76 (7.04) 0.06 (6.57)
8 (12.29) 72.17 (9.47) 73.06 (12.91) 0.88 (12.07)
15 patients on atypical
and 2 on both
atypical and typical
antipsychotics.
As baseline
474.68 (338.70) As baseline
t Reading Test (21); bPositive and Negative Symptom Scale (18); N  19
antly higher than TAU-alone; Longer latencies (p .05) in patients relative
(p  .05) at follow-up in the CBTTAU, but not in the TAU-alone, group;
.artici
ipant
men)
)
1.28)
.78)
.53)
M)
.87)
.23)
.29)
4.26)
1.80)
3.96)
nts O
hang
inus
‘3.1
‘1.6
‘4.8
‘9.6
l Adul
nific
cores
groupwww.sobp.org/journal
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wnterstimulus-interval: 1500 msec) within a diamond-shaped box
n the screen at a given delay from the original occurrence
0-back, 1-back, or 2-back; Figure 1). There were three 30-sec
ctive conditions (0-back, 1-back, 2-back) presented to partici-
ants five times in pseudo-random order, controlling for order
ffect. Each active block had 15 stimulus presentations, started
ith a 15-sec rest block (“Rest” on the screen), and began with a
50-msec text delay allowing the participants to notice a change
n task demand/condition. The experiment lasted 11.25 min.
articipants viewed the paradigm projected onto a screen
hrough a prismatic mirror. They were required to press the
utton on every trial, using the right thumb, corresponding to the
orrect location of the 0-back, 1-back, or 2-back stimulus (chance
erformance  25%; location of dots purely random). Partici-
ants abstained from alcohol for at least 24 hours and underwent
ask familiarization before scanning.
mage Acquisition
Echoplanar MR brain images were acquired using a 1.5-T GE
igna system (General Electric, Milwaukee, Wisconsin). In each
f 16 near-axial noncontiguous planes parallel to the intercom-
issural plane, 225 T2*-weighted MR images depicting blood
xygen level–dependent contrast were acquired over the exper-
ment with echo time (TE)  40 msec, repetition time (TR)  3
ec, in-plane resolution 3.1 mm, slice thickness 7.0 mm, and
nterslice gap  .7 mm. In the same session, a high-resolution
hree-dimensional inversion recovery prepared spoiled gradient
ecalled acquisition in a steady state volume data set was
cquired with TE  5.3 msec, inversion time  300 msec, TR 
2.2 msec, in-plane resolution  .94 mm, and slice thickness 
.5 mm.
ata Analysis: Demographic, Clinical, and Behavioral
easures
The HC, CBTTAU, and TAU-alone groups were compared
n age, education, and predicted IQ (21) using a one-way
nalysis of variance (ANOVA), followed by mean comparisons as
ppropriate. Group differences in performance were examined
y a Group (HC, CBTTAU, TAU-alone)  Load (0-back,
-back, 2-back) ANOVA (separately for accuracy [% correct
esponses] and latency [in msec] of correct responses) with
roup as a between-subjects factor and Load as the within-
igure 1. Illustration of 1-back and 2-back trials.ubjects factor, followed by analysis of lower order effects as
ww.sobp.org/journalappropriate. A significant Group effect in latency (Results), given
the potential effect of age in this measure, was reevaluated using
analyses of covariance (ANCOVA), covarying for age.
The CBTTAU and TAU-alone groups were compared on
clinical variables using independent-sample t tests. The change
in symptoms from baseline to follow-up was investigated using a
Group (CBTTAU, TAU-alone)  Time (baseline, follow-up)
ANOVA with Group as a between-subjects factor and Time as a
within-subjects factor. A significant Group  Time effect was
followed up by paired t tests on total and subscale PANSS scores
separately in the CBTTAU and TAU-alone groups. Following
the observation of significant symptom reduction in the
CBTTAU group, but not in the TAU-alone group, we examined
potential associations between baseline symptom severity and
symptom change (baseline minus follow-up) in the CBTTAU
group using Pearson’s correlations and confirmed the effects of
CBT-P using ANCOVAs on symptom change scores covarying for
baseline symptoms. We also computed the degree of change in
symptoms independent of initial severity as residual change in
symptoms by regressing the initial PANSS (total and subscales)
scores on follow-up scores as a further outcome measure of CBT
responsiveness for fMRI analysis following the method used by
Siegle and colleagues (22). The association between perfor-
mance variables and responsiveness to CBT was examined using
Pearson’s correlations.
All analyses were performed in SPSS windows (version 15).
Before running the described analyses, each variable was eval-
uated for the normality of the distribution to ensure it met the
criteria of parametric statistics. Alpha level for testing significance
of effects was maintained at p  .05.
Functional MRI: Image Pre-Processing
For each participant, the 225-volume functional time series
were motion corrected, transformed into stereotactic space
(Montreal Neurological Institute), smoothed with a 10 mm
full-width-at-half-maximum Gaussian filter, and band-pass fil-
tered using statistical parametric mapping software (SPM2;
http://www.fil.ion.ucl.ac.uk/spm).
Models and Statistical Inferences
Data were analyzed using a random-effect procedure (23).
Subject-specific activations were identified with a factorial model
consisting of three active conditions and rest as an implicit
baseline. Generic task-related activity changes were identified
using one-sample t tests (height threshold, p  .001; cluster-
corrected p  .05) separately in CBTTAU and HC groups.
To examine the relationship of CBT response with pretherapy
brain activity in patients, we regressed residual symptom change
scores on task-related activations (0-back vs. rest; 1- and 2-back
vs. 0-back) across the entire brain (height threshold p  .05,
cluster-corrected p  05). For the positive associations of a priori
hypothesized regions in the frontal lobe with CBT responsive-
ness, the following significance criteria to maxima voxels of
clusters that did not survive whole-brain correction for multiple
comparisons were applied: 1) T value of 3.80 (corresponding
to uncorrected voxel p .001) and100 contiguous voxels, and
2) survival of small volume correction (SVC) within a locally
defined volume (15-mm radius sphere) with family-wise error
corrected p  .05. (No cluster in any other regions met this SVC
criterion for positive associations with CBT response.) We ex-
plored negative associations between CBT responsiveness and
pretherapy activations using a more conservative criteria (height
threshold, p  .005; whole-brain cluster-corrected p  .05)
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V. Kumari et al. BIOL PSYCHIATRY 2009;66:594–602 597ecause we did not have a specific hypothesis or a region of
nterest (ROI).
To examine whether a positive association between pre-
herapy brain activity and CBT responsiveness reflected a hyper-
esponse or a stronger response within the normal range in
BTTAU patients, we compared CBTTAU patients and HC
sing two-sample t tests on 2-back  0 back contrasts (these
evealed the strongest association with CBT responsiveness; see
esults).
Further, we examined functional connectivity of the left and
ight frontal regions (that associated with CBT responsiveness in
arlier analyses) with other regions as predictors of CBT respon-
iveness. For this purpose, the activity time series from the left
LPFC (seed 48[x], 34[y], 30[z]; this had the most consistent
ositive association with CBT response) and right inferior-middle
FC (seed 52[x], 24[y], and 22[z]) were extracted (2-back 
-back) and used as a regressor (separately for left and right PFC)
o investigate their connectivity with other regions. The regions
ith significantly covarying increases or decreases in activity
ith the two ROIs were identified for each participant, and the
roup connectivity maps constructed using one-sample t tests
height threshold p  .005; cluster-corrected p  .05). The
elationship of CBT response with connectivity of the left and
ight PFC with other regions was identified by regressing residual
ymptom change scores on connectivity SPM maps in CBTTAU
atients (height threshold p  .005; cluster-corrected p  .05).
esults
emographic, Clinical, and Behavioral Measures
There was a trend for the effect of Group in age (F  2.44,
f  2,56, p  .10); TAU-alone patients were slightly older than
C (t  1.96, df  35, p  .06). There were Group effects in
ducation (F  3.53, df  2,56, p  .04) and IQ (F  4.70, df 
,55, p  .01); TAU alone patients, relative to HC, had fewer
ears in education (t  1.79, df  35, p  .01) and lower IQ (t 
.30, df  34, p  .002). CBTTAU patients did not differ from
AU-alone patients in age, education, IQ, baseline symptoms,
ge at illness onset, illness duration, and antipsychotic dose or
rom HC in demographic characteristics (Table 1).
CBTTAU, but not TAU-alone, patients showed changes in
ymptoms from baseline to follow-up (Group  Time: total
ANSS scores, F  6.74, df  1,34, p  .014; positive symptoms,
 4.42, p  .043; negative symptoms, F  4.47, p  .042;
eneral psychopathology: F  4.49, p  .041; Table 1). Only the
BTTAU group showed reduced symptoms at follow-up (total
ANSS scores: t 3.43, df 18, p .003; positive symptoms: t
.48, p  .003; negative symptoms: t  1.88, p  .07; general
sychopathology: t 3.02, p .007). Baseline symptom severity
id not correlate with CBT responsiveness (change in total
ymptoms, r  .17, p  .48). Covarying for baseline symptoms,
here was significant symptom improvement (change scores) in
he CBTTAU, relative to TAU-alone, group (total PANSS scores:
 8.16, df  1,36, p  .007; positive symptoms: F  7.01, p 
012; negative symptoms: F  8.27, p  .007; general psychopa-
hology: F  5.98, p  .02). As can be expected given earlier
oted independence between baseline symptoms and symptom
mprovement in CBTTAU patients, residual symptom change
core correlated highly positively with the absolute symptom
hange scores (total PANSS; r  .962, p  .001). Illness duration,
ducation, and IQ were not associated with CBT responsiveness
p values  .40).For performance accuracy, there was a main effect of Load
(F  91.85, df  4,106, p  .001; lower accuracy with increasing
load); Group (F  1.86, df  2,53, p  .17) and Group  Load
(F  1.66, df  2,53, p  .20) effects were nonsignificant. For
latency, there were significant Group (F  4.24, df  2,53, p 
.02; covarying for age, F  4.02, df  2,52, p  .024) and Group 
Load (F  4.24, df  2,53, p  .02; covarying for age, F  4.02,
df  2,52, p  .024) effects indicating longer latencies in both
patient groups compared to HC, especially at 1-back and 2-back
(p values .05); there was no difference between the CBTTAU
and TAU-alone groups (p values  .40). The relationships
between CBT responsiveness and performance (accuracy:
1-back, r  .33, 2-back, r  .21; latency: r  .08, r  .25),
although in the expected direction (better performance with
positive CBT response), failed to reach significance.
Generic fMRI Patterns
The generic WM network (Table 1 in Supplement 1) identified in
both the CBTTAU and HC groups included bilateral activations in
the inferior-middle-superior frontal gyrus and the parietal lobe. The
deactivated regions included the posterior cingulate, medial pre-
frontal and middle temporal gyri, insula, and precuneus.
Pretherapy Brain Activity and CBT Responsiveness
Task-Related Activity Changes. Expected associations emer-
ged between pretherapy task-related activity at 2-back ( 0-
back) and CBT responsiveness (Figure 2, Table 2); these
relationships were absent in the TAU-alone group (Figure 3).
Specifically, a reduction in total PANSS scores was associated
with greater activity bilaterally in the inferior-middle frontal
gyrus, mainly the DLPFC (BA 46). A medial PFC–anterior cingu-
late cluster (uncorrected p  .012) failed to survive SVC. A
reduction in positive symptoms was associated with greater left
inferior-middle frontal gyrus, most consistently Brodmann’s area
[BA] 9-46, activity. A reduction in negative symptoms was
associated with greater pretherapy activity in a large left-sided
cluster including the caudate, dorsomedial PFC, and DLPFC (BA
9-46). A reduction in general psychopathology was associated
with greater activity bilaterally in the inferior-middle frontal
gyrus, primarily BA 46.
No other activation was positively associated with a change in
total or subscale symptom scores at any task load. Activity in
several regions, mainly those found to be deactivated during
memory load relative to no memory load (0-back/rest) condi-
tions (Supplement 1), was associated negatively with CBT re-
sponsiveness during 1-back and 2-back ( 0-back) conditions
(Figure 2, Table 2). These relationships are due to relatively
stronger deactivations during memory load conditions in patients
with the strongest CBT response.
The CBTTAU and HC groups did not differ in activity of the
regions positively or negatively associated with CBT responsive-
ness (p values  .20).
Within the left DLPFC connectivity maps (2-back  0-back),
CBT responsiveness associated positively with covarying in-
creases in activity in a lingual gyrus-cerebellum cluster (peak:
4[x], 70[y], 4[z], T  5.20; subpeaks: 8,70, 0, T  4.84 and
2,70,14; T  4.30; 874 contiguous voxels; cluster-corrected
p  .04), and negatively with activity in the insula extending to
halamus/brainstem and middle/superior temporal gyrus (peak:
38,6,6; T  5.04; subpeaks: 4,14,4; T  4.74 and
40,12,0, T  4.67; 4187 contiguous voxels, cluster-corrected
 .001) (Figure 4). Within the right DLPFC connectivity maps(2-back  0-back), CBT responsiveness associated negatively
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with activity in the thalamus extending to parahippocampal and
osterior cingulate gyri (peak: 12,24,6; T  4.96; subpeaks:
4,46,4; T  4.83 and 4,64,12; T  4.65; 7841 contiguous
oxels, cluster-corrected p  .001).
DLPFC Connectivity. In HC, the areas of significantly cova-
ying increases with the left and right PFC activity during 2-back
 0-back) included a large area surrounding the seed voxel and
xtending to the contralateral PFC and anterior cingulate, and a
uch smaller area in the left inferior parietal cortex (BA 40)
Table 2 in Supplement 1). Similar coactivations occurred in
BTTAU patients, although the parietal cluster extended to a
uch smaller area for left DLPFC and was absent for right PFC.
osterior cingulate activity showed significantly covarying de-
reases with the left and right PFC activity in HC; this was present
eakly for left PFC and nonsignificant for right PFC in CBTTAU
roup.
iscussion
We investigated the association between pre-CBT brain activ-
ty and responsiveness to 6–8 months of CBT-P in schizophrenia
atients using an n-back task. We also studied a representative
roup of HC to enable us to characterize our patient sample.
linical Findings
Supporting the findings of meta-analyses of RCTs for CBT-P
1–3), the CBTTAU, relative to the TAU-alone, group showed
educed symptoms after CBT, with considerable variation in the
egree of symptom change for individual patients (Figure 3).
eural Findings
The activation patterns in both the CBTTAU and healthy
igure2.Brain activity associatedwith response to cognitive–behavioral th
ow shows positive associations and the bottom row negative associations
ssociated Montreal Neurological Institute coordinates (x, y, z). Left hemis
ognitive-behavioral therapy; DLPFC, dorsolateral prefrontal cortex.roups are highly consistent with previous studies using this
ww.sobp.org/journaln-back task (13,14). Supporting our hypothesis, fMRI response
increases in the frontal lobe, most consistently in the DLPFC,
during the 2-back load predicted greater responsiveness to CBT.
We found no associations between CBT responsiveness and 1)
activations during 0-back condition and 2) task-related activa-
tions of the parietal cortex. The pattern of results suggests that
cognitive processes attributed specifically to the frontal lobe,
especially DLPFC, are more pertinent to CBT responsiveness in
schizophrenia than WM in general or some other processes also
engaged by the task (see below). Supporting this suggestion, the
DLPFC activity (and not WM performance) explained a signifi-
cant amount of variance in CBT responsiveness (R2  .519,
Standard error of the estimate  9.33); the variance explained by
fMRI activity and performance together (.520, 9.32) was similar to
that explained by fMRI alone.
The task we used involves sustained attention, encoding of
information into WM, active maintenance of stimulus represen-
tations, updating of sequential order information, and response
inhibition and selection (20). Associations between task-related
fMRI activity and CBT responsiveness could therefore be inter-
preted in terms of any of these functions. However, various brain
regions constituting WM network are considered to subserve
more specialized functions. The DLPFC (BA 9-46) contributes
primarily to executive processes such as mnemonic strategies
and monitoring (24,25) and executive control of maintenance
and manipulation (26), rather than short-term storage of infor-
mation (27). The DLPFC is also critical for relational processing in
decision making (12), a function common to many higher-order
processes such as reasoning and schema induction (28). Lateral
PFC is implicated in top-down control to change behavior (29),
and brain areas involved in the top-down processing of informa-
in patientswith schizophrenia during the 2-back0-back contrast. The top
s thresholded at p .05 uncorrected) in sagittal and transverse views with
e is shown on the left of the transverse view. AC, anterior cingulate; CBT,erapy
(map
phertion are postulated to be associated with CBT responsiveness
(
a
o
D
c
T
P
T
P
N
G
N
T
P
N
G
e
V. Kumari et al. BIOL PSYCHIATRY 2009;66:594–602 59930). The positive association we report here between DLPFC
ctivity and CBT responsiveness may be mediated by facilitation
f effective CBT by executive processes modulated by the
LPFC. Patients with greater DLPFC response may be more
able 2. Brain Areas Showing Positive and Negative Associations with CBT
ositive Associations BA Cluster Size
otal Symptoms
2-back 0-back
Inferior-middle frontal gyrus 44 104
46
Inferior-middle frontal gyrus 45/46 113
46
ositive Symptoms
2-back 0-back
Inferior-middle frontal gyrus 9–46 126
44
9
egative Symptoms
2-back 0-back
Caudate nucleus n/a 1280
Anterior cingulate/medial prefrontal cortex 32/8
Middle frontal gyrus 9–46
eneral Psychopathology
2-back 0-back
Inferior-middle frontal gyrus 44 87
46
Middle frontal gyrus 46 72
egative Associations
otal Symptoms
1-back 0-back
Insula n/a 1574
Middle temporal gyrus 20/21
Parahippocampal gyrus 36
2-back 0-back
Brain stem n/a 772
Middle temporal gyrus 21
Inferior parietal lobe 40
ositive Symptoms
1-back 0-back
Transverse temporal gyrus 41 1170
Posterior cingulate 23
23/31
2-back 0-back
Brain stem n/a 659
n/a
Middle temporal gyrus 39
egative Symptoms
None
eneral Psychopathology
1-back 0 back
Middle temporal gyrus 21/20 1624
Parahippocampal gyrus 35/36
Fusiform gyrus 37
2-back 0-back
Brain stem n/a 1743
Posterior cingulate 31
Inferior parietal lobe 5
BA, Brodmannarea;MNI,MontrealNeurological Institute. In italics: SVC cr
ntire brain.apable of schema induction (facilitating transfer of learningfrom one situation to other, similar, situations), reasoning, and
relational processing (pooling together and comparing decision-
relevant information) and gain most from CBT.
Previous studies have reported hyper-, hypo-, or normal-
onsiveness in Patients
ls) Side
MNI Coordinates
Voxel T Value Corrected pX Y Z
L 54 12 26 4.85 .015
L 48 34 30 4.43
R 52 24 22 3.99 .033
R 42 24 26 2.95
L 48 32 32 4.61 .021
L 52 12 28 4.03
L 54 22 32 3.75
L 14 2 14 5.60 .001
L 6 22 52 4.57
L 46 36 28 4.55
L 54 10 26 4.51 .025
L 48 34 30 3.83
R 52 26 24 4.48 .026
L 30 28 6 5.50 .001
L 36 34 14 5.32
L 20 40 14 4.65
L 8 20 2 3.83 .006
L 60 0 10 3.65
L 50 40 48 3.54
L 30 30 10 4.94 .001
R 10 36 28 4.91
R 14 56 20 4.82
R 6 18 2 4.24 .016
R 8 12 8 3.92
R 36 62 18 3.60
L 38 32 14 5.31 .001
L 18 38 14 5.14
L 32 40 16 5.02
R 8 20 2 4.37 .001
L 24 60 18 4.09
L 24 44 54 3.94
n applied. All others: clusterp corrected formultiple comparisons across theResp
(voxe
8
2
3
2
4
3
6
9
4
3
5
5
iteriorange frontal activations in schizophrenia depending on task
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wharacteristics, as well as clinical characteristics and performance
f the patient groups (31–34). The use of atypical antipsychotics
or most patients (35), and less marked (nonsignificant) deficit in
erformance accuracy in CBTTAU patients, on average, com-
igure 3. Scatterplots of task-load-related activity (2-back 0-back) in the le
he change in symptoms (reduction from baseline) separately for the co
reatment-as-usual (TAU-alone) groups.
igure 4. Left dorsolateral prefrontal cortex (DLPFC) connectivity associa-
ion with response to cognitive–behavioral therapy (CBT) in patients with
chizophrenia during the 2-back  0-back contrast. The top row shows
ositive associations, and the bottom row shows negative associations
maps thresholded at p .005 uncorrected) in transverse views with asso-
iated Montreal Neurological Institute z coordinates. Left hemisphere is
hown on the left.
ww.sobp.org/journalpared with HC, possibly led to no patient-versus-control differ-
ences in WM-related activity in our study. The activations asso-
ciated with CBT responsiveness in our sample did not reflect
hyperactivations and were within the normal (healthy group)
range. Recent data show that schizophrenia patients with nor-
mal-range (but not poor) performance, like healthy people, can
show continued increases in DLPFC response from no/low-to-
high memory load (34), as most likely is the case for patients with
a good CBT-response in our study.
Although DLPFC activity of both hemispheres was predictive
of CBT responsiveness, the left DLPFC showed more robust
pattern of activity and connectivity with the cerebellum in
association with CBT responsiveness. This suggests that the left
hemisphere is more strongly associated with a beneficial out-
come of CBT in schizophrenia, as reported previously in depres-
sion (36). In general, bilateral activity was expected with our task
because it could be performed by encoding verbal (i.e., dot in
the left/right/top/bottom position) or spatial information and
was cognitively demanding (37).
The positive connectivity between the left DLPFC and cere-
bellum was strongly associated with a favorable response to
CBT. Although the cerebellum has traditionally been implicated
in motor control, there are stronger cerebellar projections from
the PFC in humans (30.85%) than found in nonhuman primates
(16.4%) (38), and these may have evolved in the course of
evolution following the same course as the PFC itself (39).
54, y 12, z 26) and right (x 52, y 24, z 22) frontal lobes against
e–behavioral therapy in addition to treatment-as-usual (CBTTAU) andft (x
gnitivFurthermore, recent data demonstrate cerebellar contributions to
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V. Kumari et al. BIOL PSYCHIATRY 2009;66:594–602 601igher-order cognitive functions, especially the task manage-
ent and multitasking components of executive processing (40).
he DLPFC-cerebellum connectivity and CBT responsiveness
ssociation may thus be explained by the PFC–cerebellum
ontributions to executive control, facilitating CBT responsive-
ess in the same way as the DLPFC activity itself. According to
ndreasen et al. (41–43), disruption in the corticocerebellar-
halamo-cortical circuitry results in deficient processing, priori-
izing, retrieval, coordination, and responding to information in
chizophrenia. Our findings suggest that this circuitry may also
ave a role in responsiveness to CBT in schizophrenia.
Finally, we observed strong associations between a low, or
o, response to CBT in patients and reduced deactivation of the
egions that were deactivated during the rest/0-back, relative to
he memory load, conditions in HC. These have generally been
mplicated in “mind-wandering” default states (44,45). Our find-
ng may indicate an association between a reduced ability to
aintain focus on, or switch to, a goal (task in this case) and a
ess favorable response to CBT. Clinically, disruption of default
etwork activity has been reported in several disorders including
utism (46), attention-deficit/hyperactivity disorder (47), and
chizophrenia (48–51). Our findings suggest that default mode of
rain action has a role in CBT efficacy in schizophrenia.
imitations
First, this study used a parallel-group, rather than a purely
andom, design for allocation to CBTpTAU and TAU-alone
roups. Although we cannot prove that the patients in the TAU
roup would also improve if they received CBT, the patients
ere randomly distributed across both groups in their desire for
his intervention. Second, it could be argued that CBTTAU
atients showed clinical improvement simply because of bene-
iting from therapist contact, independent of the specific effects
f the CBT methods applied to them. It is, however, unlikely
ecause the standard care provided to patients before, and
uring, the study consisted of management offered by a case
anagement team with a dedicated care coordinator who saw
he patient regularly, in addition to psychiatrists and other
pecialists, such as a benefits adviser and occupational therapist.
urthermore, CBT for psychosis has specific effects on symp-
oms, distinct from interventions such as social skills training
help acquire social skills) or cognitive remediation (improve
ognitive functioning) (1,3), and has been found superior in
educing the symptoms to a nonspecific befriending intervention
ontrolling for the amount of contact with treating professionals
52). Third, the CBTTAU and TAU-alone groups differed
lightly in IQ, education, and illness duration; none of these,
owever, had a noticeable influence in CBT responsiveness.
ourth, the use of a block design limited the interpretation of
MRI findings in terms of the component processes involved in
ask performance. Finally, we employed a spatial MW task;
erbal WM may be more pertinent to skills needed to engage in
BT.
onclusions
Within the WM network, the DLPFC activity and its connec-
ivity with the cerebellum are associated with CBT responsive-
ess in schizophrenia. These effects may be mediated by the
FC–cerebellum contributions to executive processes facilitating
ffective CBT within a psychotherapeutic context. Our results
ay imply that addressing cognitive deficits associated with
LPFC in schizophrenia would maximize benefit from CBT. This
s in line with recent data showing better outcomes with acombination of cognitive training and psychiatric rehabilitation
in schizophrenia (53,54).
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